Cargando…
Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
BACKGROUND: To develop nomograms for the prediction of the 1-, 3-, and 5-year overall survival (OS) and breast cancer-specific survival (BCSS) for patients with lymph node positive, luminal A breast cancer. METHODS: Thirty-nine thousand fifty-one patients from The Surveillance, Epidemiology, and End...
Autores principales: | Li, Yilun, Ma, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401066/ https://www.ncbi.nlm.nih.gov/pubmed/34454451 http://dx.doi.org/10.1186/s12885-021-08642-6 |
Ejemplares similares
-
Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis
por: Li, Yilun, et al.
Publicado: (2020) -
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer
por: Yue, Yuhan, et al.
Publicado: (2022) -
A nomogram for intraoperatively predicting non-sentinel lymph node metastases in early breast cancer patients with positive sentinel lymph nodes
por: Wang, Yu, et al.
Publicado: (2023) -
Development of nomograms to predict axillary lymph node status in breast cancer patients
por: Chen, Kai, et al.
Publicado: (2017) -
Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients
por: Bi, Xiang, et al.
Publicado: (2015)